Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG)
Burden of major musculoskeletal conditions.
Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art.
The kappa statistic in reliability studies: use, interpretation, and sample size requirements.
Pathophysiology and therapeutic potential of purinergic signaling.
Overweight, obesity, and health risk.
National Task Force on the Prevention and Treatment of Obesity;
Plaque production by the polyoma virus.
The fear-avoidance model of musculoskeletal pain: current state of scientific evidence.
Musculoskeletal pain in the Netherlands: prevalences, consequences and risk groups, the DMC(3)-study.
Evidence for prescribing exercise as therapy in chronic disease.
Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity.
Role of transforming growth factor-beta superfamily signaling pathways in human disease.
Psychosocial factors at work and musculoskeletal disease.
Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation.
Rituximab for steroid-refractory chronic graft-versus-host disease.
Tissue engineering: orthopedic applications.
Updating the evidence that physical activity is good for health: an epidemiological review 2000-2003.
Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000.
The consequences of childhood overweight and obesity.
The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states.